Earnings season is all over, but the dividends continue to flow into ASX investors’ bank accounts.

Hundreds of S&P/ASX All Ords Index (ASX: XAO) companies announced their next dividends during the EOFY reporting season.

We’re helping you keep track of ex-dividend dates with an article every Friday.

Here is a sample of the ASX shares due to trade ex-dividend next week.

Remember, in order to receive a dividend, you must own the ASX share before its ex-dividend date.

ASX shares with ex-dividend dates next week

ASX share	Ex-div date	Dividend	Payday
Hub24 Ltd (ASX: HUB)	7 September	42 cents per share	13 October
Pro Medicus Ltd (ASX: PME)	7 September	37 cents per share	29 September
Super Retail Group Ltd (ASX: SUL)	7 September	33 cents per share	29 September
Alkane Resources Ltd (ASX: ALK)	7 September	1 cents per share	1 October
Adairs Ltd (ASX: ADH)	7 September	6 cents per share	1 October
Perseus Mining Ltd (ASX: PRU)	7 September	9 cents per share	7 October
Bluescope Steel Ltd (ASX: BSL)	8 September	$1.35 per share	13 October
Dusk Group Ltd (ASX: DSK)	8 September	1.6 cents per share	13 October
Pepper Money Ltd (ASX: PPM)	8 September	7.2 cents per share	8 October
Regis Healthcare Ltd (ASX: REG)	8 September	9.4 cents per share	23 September
AUB Group Ltd (ASX: AUB)	8 September	71 cents per share	9 October
News Corporation (ASX: NWS)	8 September	9.9 cents per share	7 October
Motorcycle Holdings Ltd (ASX: MTO)	8 September	7 cents per share	23 September
Smartgroup Corporation Ltd (ASX: SIQ)	8 September	21.5 cents per share	23 September
Mineral Resources Ltd (ASX: MIN)	8 September	83 cents per share	30 September
CSL Ltd (ASX: CSL)	9 September	$2.78 per share	2 October
Evolution Mining Ltd (ASX: EVN)	9 September	21 cents per share	2 October
IDP Education Ltd (ASX: IEL)	9 September	6 cents per share	24 September
Brambles Ltd (ASX: BXB)	9 September	32.8 cents per share	8 October
Northern Star Resources Ltd (ASX: NST)	9 September	30 cents per share	15 October
Genesis Minerals Ltd (ASX: GMD)	9 September	5 cents per share	5 October
LGI Ltd (ASX: LGI)	9 September	1.4 cents per share	24 September
EVT Ltd (ASX: EVT)	9 September	23 cents per share	24 September
IGO Ltd (ASX: IGO)	9 September	5 cents per share	30 September
Netwealth Group Ltd (ASX: NWL)	9 September	21 cents per share	29 September
McMillan Shakespeare Ltd (ASX: MMS)	10 September	70 cents per share	25 September
SGH Ltd (ASX: SGH)	10 September	32 cents per share	9 October
Breville Group Ltd (ASX: BRG)	10 September	19 cents per share	1 October
Regis Resources Ltd (ASX: RRL)	10 September	20 cents per share	7 October
Kogan.com Ltd (ASX: KGN)	10 September	8 cents per share	30 November
Nine Entertainment Co Holdings Ltd (ASX: NEC)	10 September	3 cents per share	22 October
Sandfire Resources Ltd (ASX: SFR)	10 September	35 cents per share	30 September
Perpetual Ltd (ASX: PPT)	10 September	63 cents per share	2 October
Freightways Group Ltd (ASX: FRW)	10 September	19.9 cents per share	1 October
Globe international Ltd (ASX: GLB)	10 September	13 cents per share	25 September
Spark New Zealand Ltd (ASX: SPK)	10 September	6.1 cents per share	2 October
Cleanaway Waste Management Ltd (ASX: CWY)	11 September	3.5 cents per share	8 October
Car Group Ltd (ASX: CAR)	11 September	43.5 cents per share	1 October
WiseTech Global Ltd (ASX: WTC)	11 September	12.3 cents per share	9 October
Joyce Corporation Ltd (ASX: JYC)	11 September	17 cents per share	2 October

Check out which ASX shares begin trading ex-dividend today.

The post 40 ASX shares with ex-dividend dates next week appeared first on The Motley Fool Australia.

More reading

• ASX shares investors are getting younger and trading more often: CBA report
• 11 ASX 200 shares with reaffirmed buy ratings post-results
• How CSL shares skyrocketed 39% in August
• Buy, hold, sell: PLS Group, Catalyst Metals, Sandfire Resources shares
• Regis Healthcare reacts to government funding change

Motley Fool contributor Bronwyn Allen has positions in Dusk Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Adairs, CSL, Hub24, Kogan.com, Netwealth Group, Super Retail Group, and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Adairs, Netwealth Group, Super Retail Group, and WiseTech Global. The Motley Fool Australia has recommended Aub Group, CAR Group Ltd, CSL, Hub24, Kogan.com, LGI Limited, McMillan Shakespeare, MotorCycle, Nine Entertainment, Pro Medicus, and Smartgroup. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Australian investors continue to pour into ASX ETFs at record pace. 

Providers are likely to soon be managing over $400 billion in funds. 

While there continues to be more and more thematic and managed funds hitting the market, three funds in particular continue to dominate in terms of popularity. 

When I say “popularity”, I don’t mean public perception; rather, these three ASX ETFs are the largest funds by market cap. 

In simple terms, it means the ETFs with the most money invested in them, making them the biggest ETFs on the ASX.

These three funds are: 

• Vanguard Australian Shares Index ETF (ASX: VAS) is the largest with a market cap of $26.17 billion
• Vanguard Msci Index International Shares ETF (ASX: VGS) – $17.17 billion 
• iShares S&P 500 ETF (ASX: IVV) – $14.23 billion. 

The market cap is accurate as at July 2026 (via Betashares). 

These ASX ETFs make up fundamental parts of many investors’ portfolios. 

But which has brought the best returns?

Here is how they have performed in 2026 so far. 

Vanguard Australian Shares Index ETF

By far the largest ASX ETF is this Australian focussed fund from Vanguard. 

It has provided a stable foundation to many portfolios since its inception in 2009. 

The fund seeks to track the return of the S&P/ASX 300 Index. 

In simple terms, the 300 largest companies on the ASX by market cap. 

However, with the slow performance of the ASX through April, it has subsequently risen just over 4% in 2026. 

This is below its historical average, as the fund has brought returns of more than 8% over the last 10 years. 

It has a management fee of 0.07% p.a. 

Vanguard MSCI Index International Shares ETF

This fund is often paired with the previous fund to provide international diversification.

It invests in around 1,300 companies from developed countries, excluding Australia.

This includes some of the world’s largest companies from around 23 different countries including the U.S, Japan, U.K, Canada, France, and Switzerland.

Investing internationally offers greater access to sectors such as technology and health care that aren’t as well represented in the Australian share market.

It has also had a historically soft year, rising just over 4% since the start of 2026. 

On a per annum basis, it has risen almost 15% in the last 10 years. 

It has a management fee of 0.18% p.a. 

iShares S&P 500 ETF

This ASX ETF from iShares tracks the performance of the S&P 500 Index, before fees and expenses. 

The index is designed to measure the performance of large capitalisation US equities.

In simple terms, it targets the 500 largest companies in the United States. 

It has risen slightly more than the previous two funds, but not by much – up 4.3% in 2026. 

Historically, it has risen over 15% per year over the last 10 years. 

It has a management fee of 0.04% per annum. 

The post These are the most popular ASX ETFs – Which has performed best in 2026? appeared first on The Motley Fool Australia.

More reading

• ASX shares investors are getting younger and trading more often: CBA report
• How I’d use ASX shares to build wealth outside my superannuation
• 3 ASX ETFs that are a perfect compliment to your superannuation
• How to build an ASX portfolio you can stick with for 10 years
• How much passive income can I earn off a $630,000 superannuation balance

Motley Fool contributor Aaron Bell has positions in Vanguard Msci Index International Shares ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended iShares S&P 500 ETF. The Motley Fool Australia has recommended Vanguard Msci Index International Shares ETF and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) slid lower in August, and the share price declines continued through to early September. At the time of writing, the index is down around 1% over the past month, but is still roughly 3% higher for the year to date. 

But when the markets look weary, it’s worth looking for shares which are tipped to outperform. Here are three ASX shares that brokers are tipping to outperform the index, and they’re forecast to grow by up to 174% or more over the next 12 months.

Resmed Inc (ASX: RMD)

At the time of writing, Resmed shares have rebounded around 25% from a multi-year low in early June. But they’re still down around 11% year-to-date, and trading at $32.28 each.

The ASX healthcare sector came under fire through early 2026 as macroeconomic pressures, rising inflation, higher cost of living, and regulatory uncertainty created a sector-wide downturn. 

And ResMed was one of many ASX 200 healthcare shares caught up in the sell-off.

And the sleep disorder treatment company’s soft third-quarter earnings update in May didn’t help either. ResMed delivered an 11% (8% in constant currency) increase in revenue to US$1.4 billion. This was driven by increased demand for its portfolio of sleep devices, masks, and accessories.

But ResMed shares have bounced higher recently off the back of improved confidence around healthcare shares and a stronger fourth-quarter result last month. 

ResMed’s revenue has continued to grow at a healthy pace, and its margins have continued expanding. The company has also generated strong free cash flow. 

It looks like the ASX 200 shares are now significantly oversold and trading below fair value.

TradingView data shows the majority of brokers have a buy/strong buy rating on ResMed shares. The maximum $46.13 target price implies the shares could increase up to 43% over the next 12 months, at the time of writing.

Macquarie Group Ltd (ASX: MQG)

Macquarie shares have stormed higher in 2026, rallying strongly in April and reaching an all-time high in early August.

At the time of writing, the shares are up around 22% for the year-to-date following a series of good-news announcements.

In late July, the investment bank posted its first-quarter FY27 update, held an AGM, and announced that Greg Ward will take over Shemara Wikramanayake as Macquarie Group CEO.

As part of its results update, Macquarie described trading conditions during the first quarter as “satisfactory”. It reported that its Banking and Financial Services segment increased its profit contribution compared with the same period last year. Deposits rose by 4% during the quarter, while home loans grew by 6% and business banking loans increased by 3%.

The results followed the company’s positive earnings results back in May. At the time, Macquarie reported a full-year FY26 net profit of $4.85 billion, up 30% from FY25. It also confirmed growth across all four of its operating divisions.

Investors are thrilled with Macquarie this year, and many are still rushing to snap up the ASX 200 shares.

And brokers see lots of potential going forward, too.

Market Index data shows that the majority of brokers have a buy/strong buy rating. The maximum $290.40 target price implies the shares could jump by up to 17% over the next 12 months.

The post 2 ASX 200 shares tipped by brokers to return 17% to 43% appeared first on The Motley Fool Australia.

More reading

• How I’d use ASX shares to build wealth outside my superannuation
• Up 24%! Are Macquarie shares still a good buy today?
• How to build an ASX portfolio you can stick with for 10 years
• By September 2027, $5,000 invested in Macquarie shares could turn into…
• How to build an ASX portfolio you do not need to check every day

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.